Hair Transplant in Argentina
Hair Transplant in Argentina section, includes general infrmation about Hair Transplant Procedure, Hair Transplant Argentina Local News, Hair Transplant Argentina Surgeon Locator and other Hair Transplant related material.
Hair Transplant Procedure
Hair loss is caused by a combination of ageing, hormonal changes and a genetic history of baldness. The earlier hair loss begins, the more severe the baldness. It can also be caused by trauma, or burns, whereas this surgery is considered reconstructive.
Procedure Types
Hair Transplantation - The procedure consists of resurfacing bald areas of scalp with hair. Plugs of bald scalp are removed and then filled with plugs of scalp containing several hair roots taken from hair-bearing areas. Those grafts root themselves into their new locations and hair follicles start to grow eventually.
Depending on the degree of baldness, the number of grafts needed and the length of treatment sessions vary. Several operations may be necessary. The technique may leave many small scars on the site used (donor sites) but are usually not noticeable.
Scalp Flap Transfer – This is done when the sides of the scalp (above the ears) and the back of the scalp is hair-bearing. A long thin "flap" of scalp that is hair-bearing is removed and placed across a bald section to create a band of normal hair growth. As part of the treatment, parts of the bald scalp may be removed. The donor site is closed by stretching the opposite side of the scalp.
This procedure replaces hair across a large area of bald scalp. The hair growth looks normal, and the narrow scars are hidden between the hair follicles.
Scalp Reduction (Serial Excision) – This is the removal of as much of the bald section as possible and done in the first operation. The adjacent hair bearing areas of scalp are pulled in close to the bald section, with the understanding that some bald areas will remain. This technique is repeated one or more times at a later date to eventually reconstruct the bald area.
Tissue Expansion – A device called a tissue expander is placed under a hair growth area situated adjacent to a bald area. After several weeks, the tissue expander causes skin to grow new skin cells. Then another operation is necessary to place the newly expanded skin over the ajoining bald area.
Ideal candidates for hair replacement must have a healthy growth of hair at the back and sides of the head. The hair on the back and sides of the head will be the donor sites where the flaps and grafts will be surgically removed.
The procedure location options may include the surgeon's office-based surgical facility, outpatient surgery center, hospital outpatient, or hospital in patient.
The anesthetic options are either general, or local (combined with a sedative)which allows the patient to remain awake but relaxed.
To achieve desired fullness, several surgical sessions are needed. There is a healing period of several months recommended between each session. The final result with a full transplant series may take up to 2 years.
A month or 2 after surgery, the grafted hair falls out (which is normal and temporary). It takes another month or more before hair growth starts. To create more natural-looking results, a surgical touch-up procedure may be necessary. This may consist of using a combination of mini grafts or slit grafts to fill and blend in the hairline.
Other Hair Transplant Procedures
All Skin Procedures
Hair Transplant Argentina (current)
Hair Transplant Argentina Chemical Peel
Hair Transplant Argentina Dermabrasion
Hair Transplant Argentina Laser Hair Removal
Hair Transplant Argentina Collagen Injections
More Argentina info...
Argentina History Following independence from Spain in 1816, Argentina experienced periods of internal political conflict between conservatives and liberals. In the first decade of the 20th century, Argentina became the richest nation in Latin America, its wealth symbolized by the opulence of its capital city.
European immigrants flowed into Argentina, particularly from Italy; by 1914 nearly 6 million people had come to the country.
After World War II, a long period of Peronist rule in subsequent governments was followed by a military junta that took power in 1976.
Democracy returned in 1983 after the abortive attempt to wrest the Falkland Islands (Islas Malvinas) from United Kingdom sovereignity.
A painful economic collapse at the turn of the 21st century devalued the Argentine peso by a factor of three and ushered in a series of weak, short-lived governments along with social and economic instability. As of 2006, the country has stabilized under President Nestor Kirchner, and the economy has begun to recover.
Argentina Cities The largest cities are:
Buenos Aires or "Ciudad Aut?noma de Buenos Aires", usually called Capital Federal to distinguish it from the province of Buenos Aires.
C?rdoba, second largest.
La Plata, capital of the most important state, and known as "the perfect city" for its tracing (see map).
Mendoza, fourth largest, well known for its extensive and high quality wine production.
Rosario, third largest city.
San Juan, the tenth largest city, capital of the province of San Juan, and a center of quality wine production. There are also a lot of medium-sized towns, like
Plastic Surgery News...
- Genetic studies in animals need to be replicated in humans Melanomas could be treated using an "anti-tumour protein", reports The Guardian, adding that the protein "puts cells into hibernation or makes them commit suicide if they start to get cancerous". This research "could be used as a new way to threat the notoriously aggressive cancer", the article adds.
- A systematic review and meta-analysis published early online in the Lancet Oncology has concluded that patients taking sorafenib have a statistically significant risk of developing hypertension.
Researchers conducted a systematic review and meta-analysis of 9 clinical trials in which a total of 4599 cancer patients (renal cell carcinoma or other solid tumours) had been randomised to receive sorafenib 400mg twice daily, and the incidence of hypertension was reported in the safety data.
The following results were reported:
• Sorafenib was associated with a statistically significantly increased risk of all-grade hypertension in patients with cancer, with a relative risk RR of 6.11 (2.44–15.32], p<0.001) compared with controls.
• For patients assigned sorafenib, the overall incidence of all-grade and high-grade (i.e. grade 3 or 4) hypertension were 23.4% (95% CI 16.0–32.9%) and 5.7% (2.5–12.6%), respectively.
• No significant difference was noted between patients with RCC or a non-RCC malignancy (all grade: RR 1.03 [95% CI 0.73–1.45], p=0.89; high-grade: RR 1.23 [0.76–1.99], p=0.40) who were assigned sorafenib.
The authors also conclude that appropriate monitoring of patients taking sorafenib is strongly recommended to prevent cardiovascular complications.
[Absolute risk figures were not available in the abstract]